Escobar Soto, Carlos HugoAngus D, Linde-Zwirble, Lidicker J, Clemont G, Carcillo J, Pinsky M. Epidemiology ofsevere sepsis in the United States: analysis ofincidence, outcome, and associated costs ofcare. Crit Care Med. 2001; 29: 1303-1 O. 2. Martín G, ManninoD, Eaton S, Moss M. Tbe epidemiology ofsepsis in the United States from 1979 through 2000. N Eng!J Med. 2003; 348: 1546-54. 3. Riedemann N, Guo R, Ward P. The enigma ofsepsis. J Clin Invest. 2003; 112:460--67. 4. Hotchkiss RS, Karl IE. Toe pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348:138 50. 5. Riedemann NC, Guo R, Ward PA. Novel strategies for the treatrnent of sepsis. Nat Med. 2003; 9:517-24. 6. Hattori Y, Takano K, Teramae H, Yamamoto S, Yokoo H, Matsuda N. Insight into sepsis therapeutic design based on the apoptotic death pathway. J Pharmacol Sci. [serie en Internet]. 2010 [citado 2011 Feb 1]; 114 (4):[aprox. 12 p.]. Disponible en: http://www.jstage.jst.go.jp/article/jphs/advpub/O/ advpub_l0l1100472/_article 7. Y....
,
2022
